Category: Middle East and North Africa

June 15, 2020 Off

Hikma, Sun Pharma in licensing agreement for Ilumya for the MENA region

By Dino Mustafić

Hikma Pharmaceuticals and a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd. (Sun Pharma), the world’s fourth largest specialty generic pharmaceutical company, announced today that they have entered into an exclusive licensing and distribution agreement for Ilumya, an innovative biologic product, for the Middle East and North Africa (MENA) region.

June 12, 2020 Off

CPhI Middle East & Africa to debut in Saudi Arabia in 2021

By Dino Mustafić

CPhI Middle East & Africa has been cancelled due to the COVID-19 pandemic, the 2020 edition of the show, scheduled to take place in September in Abu Dhabi. A new earlier date and location for the event has been disclosed, with the show debuting in Riyadh, Saudi Arabia on March 2021.

November 27, 2019 Off

HIkma responds to FDA about GSK’s Advair Diskus

By Dino Mustafić

Hikma has submitted to the US Food and Drug Administration (FDA) its response to deficiencies in its abbreviated new drug application (ANDA) for a generic version of GlaxoSmithKline’s Advair Diskus® (fluticasone propionate and salmeterol inhalation powder).